Beckman Coulter, Inc. (BEC)

sportybostonian (24.97) Submitted: 5/5/2009 4:07:27 PM : Start Price: $54.04 BEC Score: -0.27

Solid recurring revenue. Should also benefit from stimulus grants.

corpblues (98.33) Submitted: 3/3/2009 12:36:38 PM : Start Price: $40.43 BEC Score: +2.75

Not sure if I agree with Dorsey on this one but I'll step out there with monopoly money.

Beckman Coulter (BEC). This mid-size health-care firm is an attractive target for several reasons. For starters, around 80% of its revenue comes from recurring sources, such as the reagents used in the testing equipment Beckman sells to hospital labs. The firm also has a key unit focused on modern diagnostic technologies that's growing 15% to 20% a year, which is considered light speed in this mature industry.

Finally, Beckman, whose shares are trading at a modest P/E of around 14, is one of the last pure-play medical testing firms left standing. So it would be a logical target for a large player looking to enter this health-care niche.

Pat Dorsey is the director of equity research for Morningstar.

TMFHelical (98.19) Submitted: 1/28/2009 10:38:20 AM : Start Price: $47.50 BEC Score: +8.62

Increased NIH spending should be a benefit for those companies whose product support biotechnology research. They have been beaten down with the market but maintain strong fundamentals as a group.

buccaneergal (< 20) Submitted: 6/11/2008 11:02:40 AM : Start Price: $68.41 BEC Score: +11.07

This also happens to be my initials and if you can't bet on yourself, who can you bet on? :D

septicskeptic (23.83) Submitted: 3/12/2008 7:03:14 PM : Start Price: $63.17 BEC Score: +15.23

large minneapolis location

PAINT48 (62.19) Submitted: 11/27/2007 12:43:14 AM : Start Price: $67.55 BEC Score: +15.65

American Diagnostic equipment manufacture with great product line up and great presence world wide and 30% us market share

jandmamck (43.89) Submitted: 3/27/2007 2:23:41 PM : Start Price: $61.33 BEC Score: +25.38

on the right track-doing things properly

DanceWithWolf (50.52) Submitted: 3/26/2007 10:12:11 AM : Start Price: $60.17 BEC Score: +27.42

Drop on acquisition unwarranted